Conference: Cell and Gene Meeting on the Med

As a board member of the Alliance for Regenerative Medicine and founding member of the Alliance for mRNA Medicines, our team is thrilled to attend this year’s Meeting on the Med where thought leaders will convene to discuss the latest advancements in transformative medicines.

Plenary Session: A Forecast on the 2024 CGTx Landscape​ | Tuesday, April 9th, 2024 | 5:15pm CET

Abstract

• Current state of the regenerative medicine and advanced therapies sector 
• New technologies, bottlenecks, and solutions 
• Predictions on potential approvals in 2024
• Improving patient access
• Evolution of CMC and manufacturing

Panelists

• [MODERATOR] Anshul Mangal (President, Project Farma)
• Igor Bilinsky, Ph.D. (COO, Iovance Biotherapeutics)
• Phil Cyr (Sr. Vice President, Precision Value & Health)  
• Doug Danison (Head of Commercial, Cell and Gene Therapy Unit, Bayer)
• Stefan Irion, M.D. (CSO, BlueRock Therapeutics) 
• Helen Sabzevari, Ph.D. (President and CEO, Precigen)

Click here to learn more!